Dr. Mamounas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Orlando Health Cancer Institute
1414 Kuhl Ave
Orlando, FL 32806- Is this information wrong?
Education & Training
- UPMC Medical EducationResidency, Surgery, 1984 - 1989
- University of AthensClass of 1983
Certifications & Licensure
- FL State Medical License 2012 - 2023
- OH State Medical License 1997 - 2014
- PA State Medical License 1985 - 1998
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Evaluating Regional Nodal Irradiation Allocation and Association with Oncologic Outcomes in NSABP B-18, B-27, B-40, and B-41.Raymond B Mailhot Vega, Shu Wang, Eric D Brooks, Oluwadamilola T Oladeru, Natalie A Lockney, Lisa E Spiguel, Shannon M MacDonald, Eleftherios P Mamounas, Nancy P Mende...> ;International journal of radiation oncology, biology, physics. 2022 Jul 1
- 12 citationsTrastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trialsRosie Bradley, Jeremy P Braybrooke, Richard Gray, Robert Kerrin Hills, Z Liu, Richard Peto, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn W. Taylor, S...> ;Lancet Oncology. 2021 Aug 1
- Characteristics of residual invasive breast cancer after neoadjuvant therapy in the KATHERINE study.Eleftherios P. Mamounas> ;Annals of Oncology. 2021 May 29
- Join now to see all
Journal Articles
- 21-Gene Assay as Predictor of Chemotherapy Benefit in HER2-Negative Breast CancerEleftherios P Mamounas, Frederick L Baehner, Norman Wolmark, D Lawrence Wickerham, Nature
- Clinical Relevance of the 21-Gene Recurrence Score® Assay in Treatment Decisions for Patients with Node-Positive Breast Cancer in the Genomic EraEleftherios Mamounas, MD, Nature
Lectures
- NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ...2019 ASCO Annual Meeting - 6/1/2019
- NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ...2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
- Do Trials Results Conflict for Extended AI in Breast Cancer?December 8th, 2016
- 21-Gene Recurrence Score for Prognosis and Prediction of Taxane Benefit After Adjuvant Chemotherapy plus Endocrine Therapy: Results from NSABP B-28/NRG OncologyNovember 11th, 2019
- Conversations with Oncology Investigators Bridging the Gap Between Research and Patient CareDecember 26th, 2007
Professional Memberships
- Member
- Member
Hospital Affiliations
- Orlando Regional Medical CenterOrlando, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: